Stonepine Capital Management
Stonepine Capital Management reported 66 stocks worth $120M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are VSTM (20.4%), CAMP (9.4%) and EOLS (6.5%). Compared with Q2 2026, the fund opened new positions in BSX, PYXS and SRZN, added to CAMP, KZIA and RARE, trimmed VSTM, EOLS and ADMA and sold out of RADX, TELA and CRIS.
Latest filing: what Stonepine Capital Management did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() VSTM Verastem Inc | $24.5M | 20.4% | 3M | −307K (−9%) | 8 of 8 | |
| 2 | ![]() CAMP CAMP4 Therapeutics Corp | $11.3M | 9.4% | 2.8M | +1.4M (+101%) | 4 of 8 | |
| 3 | ![]() EOLS Evolus Inc | $7.8M | 6.5% | 972K | −619K (−39%) | 8 of 8 | |
| 4 | ![]() ADMA Adma Biologics Inc | $7M | 5.9% | 700K | −40K (−5%) | 8 of 8 | |
| 5 | ![]() NKTR Nektar Therapeutics | $6.7M | 5.6% | 110K | −11K (−9%) | 6 of 8 | |
| 6 | ![]() ELOX Eloxx Pharmaceuticals Inc | $5.8M | 4.9% | 382K | −15K (−4%) | 2 of 8 | |
| 7 | ![]() MSLE Satellos Bioscience Inc | $3.9M | 3.2% | 455K | −37K (−7%) | 3 of 8 | |
| 8 | ![]() KZIA Kazia Therapeutics Ltd | $3.6M | 3.0% | 377K | +32K (+9%) | 4 of 8 | |
| 9 | ![]() INDV Indivior PLC | $3.6M | 3.0% | 100K | No change | 2 of 8 | |
| 10 | ![]() RARE Ultragenyx Pharmaceutical in | $3.2M | 2.6% | 210K | +185K (+740%) | 3 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() RADX Radiopharm Theranostics Ltd | $211M | 51M |
![]() TELA Tela Bio Inc | $2M | 2.7M |
![]() CRIS Curis Inc | $1.7M | 3.3M |
![]() SPRB Spruce Biosciences Inc | $1.6M | 29K |
![]() SLGL Sol Gel Technologies | $1.1M | 14K |
🔒 Free account: see all 24.
Options
valued at the underlying shares| Stock | Type | Value | Shares | Change |
|---|---|---|---|---|
![]() INSM Insmed Inc | Call | $5.6M | 40K | 0 |
![]() ADMA Adma Biologics Inc | Call | $5.2M | 400K | −250,000 |
![]() EOLS Evolus Inc | Call | $5M | 500K | +80,000 |
![]() ZLAB Zai Lab Ltd | Call | $4.5M | 150K | +150,000 |
![]() ESTA Establishment Labs Hldgs Inc | Call | $4.3M | 50K | +50,000 |
🔒 Free account: see all 12.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 13, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Stonepine Capital Management 13F FAQ
What does Stonepine Capital Management own?
Stonepine Capital Management reported 66 stocks worth $120M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are VSTM (20.4%), CAMP (9.4%) and EOLS (6.5%). The table above lists every position in the filing (the top 10 without an account).
What did Stonepine Capital Management buy and sell in Q3 2026?
Compared with Q2 2026: 18 new positions, 20 added to, 26 trimmed and 24 sold out. New positions include BSX, PYXS and SRZN. It sold all of RADX, TELA and CRIS.
When will Stonepine Capital Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Stonepine Capital Management's portfolio worth?
The Q3 2026 filing reports $120M in US stocks ($159M including options). That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.




























